424B3

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

SEC Filing Details

Document Details

Form
Filing Date
Feb 2, 2022
Document Date
Feb 2, 2022
Form Description
Form of prospectus reflecting facts events constituting substantive change from last form
Filing Group
Registration Statements
Company
KemPharm
Issuer
KEMPHARM, INC